Atomoxetine Titration Week by Week: What to Expect on Strattera
A week-by-week guide to atomoxetine (Strattera) titration for ADHD: the label's dose steps, how onset builds over weeks, side effects, CYP2D6, and what to ask your prescriber.
Typical Atomoxetine curve
Population average for a dose at 8am. Yours will differ, and that gap is what logging shows.
Get new titration guides by email
Occasional, evidence-based guides on medication tracking and titration — no noise.
Disclaimer: This article is for educational and informational purposes only. It does not constitute medical advice, diagnosis, or a prescription recommendation. All medication decisions must be made by you and your licensed healthcare provider based on your individual medical history and circumstances. The dosing ranges cited are drawn from the FDA prescribing information and the NICE NG87 guideline; your prescriber may follow a different plan appropriate to your specific needs.
Atomoxetine — sold under the brand name Strattera in the US and other markets — is the most widely studied non-stimulant medication for ADHD. It works very differently from stimulants: no same-day effect, no peak or crash, and no controlled-substance scheduling. A single daily dose can cover the whole day [2], and the label found no symptom rebound when it was stopped [1]. It still has side effects of its own, including nausea, lower appetite and trouble sleeping in some adults [1].
The trade-off is patience. Atomoxetine builds slowly: it can start helping within 1–2 weeks, and the response can keep growing for months [2]. The early weeks can feel slow or discouraging. This guide explains the week-by-week timeline, what to expect, what to log, and why it helps to know about the slow build before you start.
For a broader comparison of non-stimulant options, see our complete guide to non-stimulant ADHD medications.
Does Strattera work on the first day?
No. Strattera (atomoxetine) does not work right away the way a stimulant does. Some people notice small changes within the first 1–2 weeks, and the effect can keep building for up to 24 weeks or longer [2]. The first week is mostly about whether your body tolerates it. If you feel nothing on day one, or even in week one, that is common and not on its own a sign it has failed.
How atomoxetine works
Atomoxetine is a selective norepinephrine reuptake inhibitor (NRI). The label says its exact mechanism in ADHD is unknown but is thought to come from blocking the norepinephrine transporter [1]. In rat studies it raised norepinephrine and dopamine in the prefrontal cortex, the brain region involved in attention and impulse control, but did not raise dopamine in the nucleus accumbens (the reward center), unlike methylphenidate [3]. The label reports no stimulant or euphoriant effects in an abuse-potential study, and atomoxetine is not a controlled substance [1].
Why the effect builds slowly is not fully understood. Researchers have suggested gradual changes in how the brain adapts to the drug [2]. In practice, it means atomoxetine needs a different mindset from stimulant treatment.
Atomoxetine dosing and titration schedule
Atomoxetine comes in several capsule strengths, and the prescribing information describes a gradual build-up with an option to split the daily amount into morning and late-afternoon doses if side effects are a problem. Your prescriber decides the starting dose, how quickly to move, and where to stop. That choice depends on your history, other medications, how you metabolize the drug, and how you respond. Titrate does not suggest doses.
The US label sets out two schedules, and in both the dose goes up in steps rather than starting at the target [1]:
- Adults, and teens who weigh 70 kg or more: the label starts at 40 mg a day, raises it after at least 3 days to a target of 80 mg a day, and allows up to 100 mg a day if the response at 80 mg is not good enough after another 2 to 4 weeks.
- Children and teens under 70 kg: dosing goes by body weight, starting at 0.5 mg/kg a day and moving after at least 3 days to a target of 1.2 mg/kg a day. The maximum is 1.4 mg/kg or 100 mg a day, whichever is lower.
The daily amount can be taken once in the morning or split between morning and late afternoon. For people who process atomoxetine slowly (CYP2D6 poor metabolizers) or who take a strong CYP2D6 inhibitor, the label suggests a longer gap of 4 weeks between steps if symptoms haven't improved and the first dose is well tolerated. These are the label's numbers, not a plan: your prescriber sets your own starting dose and pace, and that is the Strattera titration this guide follows week by week.
What you can do is make the pattern easy to read. Prescribers typically review at intervals, and the timeline below is about what to watch for, not what to take [1].
| Phase | What you might notice | What to log |
|---|---|---|
| Week 1 | Mostly a tolerability check; benefit is usually small or absent | Dose time, side effects, sleep, appetite |
| Week 2 | Early side effects (nausea, fatigue, dry mouth) may appear; some people notice first changes | Side-effect severity, any early changes |
| Week 3 | Small improvements in attention or impulse control may become easier to see | Small wins, focus, impulsivity |
| Weeks 4-6 | Effect keeps building; benefits often become clearer | Daily function, mood, ongoing side effects |
| Week 8+ | Response can keep growing; you and your prescriber judge response and tolerability | Overall pattern for your review |
Week 1 — starting dose: tolerability only
In the first week, most people don't feel much ADHD improvement yet. This week is mainly about whether your body tolerates the medication. The most common side effects in the label's adult trials, compared with placebo, were [1]:
- Nausea (26% vs 6%)
- Dry mouth (20% vs 5%)
- Decreased appetite (16% vs 3%)
- Trouble sleeping (15% vs 8%)
- Fatigue (10% vs 6%) or sleepiness (8% vs 5%)
What to log:
- Time you took the dose
- Any side effects and their severity (1–5)
- Sleep quality
- Appetite and meals
- Any anxiety or mood changes
If side effects are severe, contact your prescriber.
Week 2 — early effects: mostly side effects
Many people find week 2 hard. Side effects may still be there, while benefits are small or hard to see. It is easy to decide the medicine isn't working at this point, which is why it helps to know in advance that atomoxetine builds slowly [2].
Why this happens: atomoxetine's effect grows gradually over weeks to months, even though the drug itself is cleared from the blood within a day [1][2]. The reason for this slow build is still being studied.
What to log:
- Same side-effect checklist as week 1
- Any subtle changes in attention, impulse control, or emotional regulation (even if uncertain)
- Sleep quality and timing
- Energy levels throughout the day
If nausea or other side effects are bothering you, ask your prescriber whether splitting the daily amount into morning and late-afternoon doses, which the label allows, would help [1].
Week 3 — first subtle benefits
By week 3, some people notice the first hints of improvement. These are usually subtle and may include:
- Slightly easier task initiation
- Less internal restlessness
- A quieter mental background
- Better tolerance for boring or repetitive tasks
- Slightly improved emotional regulation (less reactive)
These effects are not dramatic. They are often best detected by comparing specific behaviors week over week rather than by overall mood.
What to log:
- Functional tasks: did you complete more work tasks? Were you on time more often?
- Social interactions: fewer interruptions? Less frustration?
- Emotional regulation: fewer irritable outbursts? Less overwhelm?
- Side effects: are they improving or worsening?
Week 4–6 — effect builds
For many people who respond, this is when the benefit becomes easier to see. By week 4–6, you might notice:
- More consistent focus across the day
- Less need for external pressure to start tasks
- Better working memory in daily life
- Reduced impulsivity in conversations and decisions
- More stable emotional tone
If you have been on a stable dose for several weeks and still feel nothing, bring your log to your prescriber. They may:
- Continue for longer, since response can keep building for months [2]
- Decide whether a dose change makes sense
- Consider that atomoxetine may not be right for you and discuss alternatives
How long to wait before judging atomoxetine is your prescriber's call. Because its effect builds slowly, it is worth asking at the start how long they plan to give it [2].
Week 8+ — full therapeutic effect and maintenance
By week 8, many people have a clearer picture of atomoxetine's effect, although it can keep improving after that [2]. For comparison, the two adult trials behind its approval ran for 10 weeks and found it better than placebo for both inattentive and hyperactive-impulsive symptoms [4]. At this stage, the questions are:
- Is the benefit strong enough to continue?
- Are side effects manageable?
- Is my current dose right for me, or should we talk about changing it?
- Would adding another medicine help?
Some prescribers combine atomoxetine with a stimulant when atomoxetine alone gives only partial benefit. This combination is less studied than atomoxetine on its own and is not covered by the Strattera label, so it is something to discuss with your prescriber rather than try on your own.
Atomoxetine side effects and management
| Side effect | What the label reports | What to raise with your prescriber |
|---|---|---|
| Nausea / GI upset | Nausea 26% vs 6% in adults | Whether a split dose would help |
| Fatigue / sleepiness | Fatigue 10% vs 6%, somnolence 8% vs 5% in adults | Whether dose timing could help; take care driving until you know how it affects you |
| Dry mouth | 20% vs 5% in adults | Whether it is bothering you |
| Decreased appetite | 16% vs 3% in adults | Any weight change |
| Sexual side effects | Erectile dysfunction in 8% of men vs 1% | Raise it even if it feels awkward; the label says these effects are likely under-reported |
| Increased heart rate / BP | Average heart rate rose by a few beats a minute, more in slow metabolizers | Whether to check heart rate and blood pressure at home |
| Mood changes | Boxed warning for suicidal thoughts in children and teens | Report suicidality or severe agitation immediately |
All figures are from the label's adult trials [1].
Atomoxetine carries a boxed warning for suicidal thoughts and behaviors in children and teens, with close monitoring advised especially in the first months and after dose changes [1]. A meta-analysis of the trials found suicidal ideation was uncommon, was reported more often than with placebo in children and teens, and was not higher than placebo in adults [5]. Adults should still report any new or worsening mood symptoms, suicidal thoughts, or severe agitation to their prescriber immediately.
CYP2D6: the genetic factor that changes your dose
Atomoxetine is broken down mainly by the liver enzyme CYP2D6 [1]. People fall into different metabolizer categories:
- Normal, intermediate and ultrarapid metabolizers: the label uses the standard dosing schedule.
- Poor metabolizers: process atomoxetine slowly. In the label's adult data they had more side effects (for example dry mouth in 35% vs 17%) and larger heart rate rises, and the label suggests a longer gap between dose steps.
The label says prescribers can consider genetic testing to find out a person's CYP2D6 status. Some antidepressants, such as fluoxetine and paroxetine, strongly inhibit CYP2D6 and raised atomoxetine exposure 6- to 8-fold in a study [1].
Atomoxetine vs. stimulants: when to choose which
| Factor | Atomoxetine | Stimulants |
|---|---|---|
| Onset | Builds over weeks to months | Same day |
| Duration | Steady through the day with regular dosing | Hours per dose, varies by formulation |
| Peak/crash | None | Present, varies by formulation |
| Appetite | Decreased appetite in 16% of adults [1] | Often suppressed |
| Sleep | Insomnia in 15% of adults vs 8% on placebo [1] | Can disrupt sleep |
| Controlled substance | No | Yes (Schedule II in the US) |
| Convenience | Once or twice daily | Once or multiple times daily |
| Effect size | Moderate | Larger on average [6] |
NICE recommends offering atomoxetine to adults who can't tolerate lisdexamfetamine or methylphenidate, or whose symptoms haven't responded to separate 6-week trials of both [7]. Whether it fits you also depends on things like other conditions and medicines, which is a conversation for your prescriber.
Track your atomoxetine titration with Titrate
Atomoxetine's slow onset makes memory-based reporting especially unreliable. You may not remember whether your focus was slightly better in week 3 or week 5, and your prescriber needs that detail to decide whether to continue, increase, or switch.
Titrate is designed for this. Daily check-ins track dose, side effects, sleep, and functional markers. Over the weeks, the data shows whether the gradual effect is real, and gives your prescriber a clear basis for the next decision.
→ Start tracking your atomoxetine titration free ← → See how prescribers view Titrate reports ←
Also see our complete guide to non-stimulant ADHD medications and stimulant titration timelines.
FAQ
Q: What if I feel nothing for the first 3 weeks? That's common. Atomoxetine does not work like a stimulant: it can start helping within 1–2 weeks, but the effect keeps building for weeks to months [2]. Bring your log to your prescriber rather than deciding on your own that it isn't working.
Q: How quickly does Strattera work? Slowly. There is no same-day effect. Side effects can show up in week 1, small improvements can appear within the first 1–2 weeks, and the response can keep growing for up to 24 weeks or longer [2].
Q: Can I take atomoxetine only on days I need to focus? The label's dosing is every day, once or twice daily, and its effect builds with regular use [1][2]. It is not designed as an as-needed medicine, so talk to your prescriber before skipping doses.
Q: Can I drink coffee while taking atomoxetine? The Strattera label does not list caffeine as an interaction [1]. Both can raise heart rate, though, so ask your prescriber if you drink a lot of it, and keep your intake steady so your log is easier to read.
Q: Can atomoxetine be taken at night? The label describes taking it once in the morning, or splitting it between morning and late afternoon [1]. If you're wondering about a different time, for example because it makes you sleepy, ask your prescriber.
Q: Can I take atomoxetine with stimulants together? Some prescribers do combine them when atomoxetine alone gives only partial benefit, but the combination is less studied and is not covered by the Strattera label. Only combine medicines under your prescriber's care.
Q: What are the most serious side effects? Seek urgent medical help if you experience severe chest pain, shortness of breath, fainting, severe agitation, hallucinations, or suicidal thoughts. The label also warns about rare liver injury, so contact your doctor promptly about itching, yellowing skin or eyes, dark urine, tenderness in the upper right belly, or unexplained flu-like symptoms [1]. Report new or worsening mood symptoms to your prescriber promptly.
Q: Does atomoxetine work as well as stimulants? On average, stimulants have larger effect sizes in clinical trials [6]. But an average doesn't decide what works for one person. For some people atomoxetine is the better fit, for example because they can't tolerate stimulants or because of other conditions they have.
Key takeaways
- Atomoxetine (Strattera) is a non-stimulant NRI whose effect builds over weeks to months.
- The first 2 weeks are mostly about tolerability. Knowing about the slow build helps you avoid judging it too early.
- Dosing is your prescriber's decision. Log your response and side effects so they have what they need to decide.
- Side effects differ from stimulants' and include nausea, dry mouth, lower appetite and trouble sleeping. A split dose or a slower pace may help; ask your prescriber.
- CYP2D6 metabolism matters. Poor metabolizers have higher levels and more side effects, and the label slows their titration.
- NICE offers atomoxetine to adults when stimulants aren't tolerated or haven't worked.
- Structured tracking is essential because the effect is gradual and easy to miss from memory alone.
References
- Strattera (atomoxetine) — FDA Prescribing Information. DailyMed: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=309de576-c318-404a-bc15-660c2b1876fb
- Clemow DB, Bushe CJ. Atomoxetine in patients with ADHD: a clinical and pharmacological review of the onset, trajectory, duration of response and implications for patients. J Psychopharmacol. 2015;29(12):1221–1230.
- Bymaster FP, et al. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology. 2002;27(5):699–711.
- Michelson D, et al. Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biol Psychiatry. 2003;53(2):112–120.
- Bangs ME, et al. Meta-analysis of suicide-related behavior or ideation in child, adolescent, and adult patients treated with atomoxetine. J Child Adolesc Psychopharmacol. 2014;24(8):426–434.
- Cortese S, et al. Comparative efficacy and tolerability of medications for ADHD in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2018;5(9):727–738.
- NICE. Attention deficit hyperactivity disorder: diagnosis and management (NG87). https://www.nice.org.uk/guidance/ng87
This article is for educational purposes only. It does not constitute medical advice. Always consult your licensed healthcare provider about medication decisions.